| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/14/2002 | US6387648 Method for adjusting and disinfecting liquids |
| 05/14/2002 | US6387647 Cytochrome P-450 reductase screen for ergosterol biosynthesis inhibitors |
| 05/14/2002 | US6387646 Reagent compositions for measuring electrolyte |
| 05/14/2002 | US6387643 Amino acid sequence; antiinflammatory agents; antiarthritic agents; anticarcinogenic agents |
| 05/14/2002 | US6387640 Screenig for compounds which modulate ataxia telangiectasia-mutated kinase by detecing change in level of phosphorylation of polypeptide with defined amino acid sequence; increase indicates agonist; decrease indicates antagonist |
| 05/14/2002 | US6387635 2′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 05/14/2002 | US6387632 Polynucleotide separation method and apparatus therefor |
| 05/14/2002 | US6387631 Silylating a support, e.g. glass, with an aminoalkylsilane silane-triol or -trihalide; activating with a crosslinker; reacting with an amine-containing polymer and attaching target biomolecules in a defined way; stability; gene mapping |
| 05/14/2002 | US6387630 Methods for diagnosing multiple myeloma by determining rejection antigen precursors |
| 05/14/2002 | US6387629 Use of cathepsin S in the diagnosis and treatment of endometriosis |
| 05/14/2002 | US6387627 Phagemid for antibody screening |
| 05/14/2002 | US6387626 Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces |
| 05/14/2002 | US6387625 Monolayer and electrode for detecting a label-bearing target and method of use thereof |
| 05/14/2002 | US6387621 Automated analysis of real-time nucleic acid amplification |
| 05/14/2002 | US6387620 Transcription-free selex |
| 05/14/2002 | US6387619 Telomerase compositions and methods |
| 05/14/2002 | US6387618 Micronucleus assay with genomic DNA hybridization probe and enzymatic color pigment detection |
| 05/14/2002 | US6387617 Proto-nucleozyme having catalytic activity in presence of non-nucleic cofactor which chemically interacts to provide missing component; viricides; anticarcinogenic agents |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387615 Methods and materials for the diagnosis or prognosis of asthma |
| 05/14/2002 | US6387614 Using electrochemical biosensor with liposomes of glycine-terminated diacetylene lipid, acetylferrocenic diacetylene lipid, and glycosphingolipid; drop in current is indicative of specific biomolecular recognition |
| 05/14/2002 | US6387268 Immobilization of membrane receptor on HPLC |
| 05/14/2002 | US6387232 Membrane for a sensor |
| 05/14/2002 | US6386113 Non-lethal weapon systems |
| 05/14/2002 | CA2147852C Bacillus circulans based biological indicator for gaseous sterilants |
| 05/14/2002 | CA2032907C Hepatitis c assay |
| 05/10/2002 | WO2002037209A2 System, method, and computer software product for linked window interfaces |
| 05/10/2002 | WO2002037202A2 Nonlinear system identification for class prediction in bioinformatics and related applications |
| 05/10/2002 | WO2002037114A1 Agent for detecting cancer's ability to metastasize |
| 05/10/2002 | WO2002037112A2 Detection of ovarian cancer |
| 05/10/2002 | WO2002037109A2 Detection of binding species with colloidal and non-colloidal structures |
| 05/10/2002 | WO2002037106A2 Methods for comparitive analysis of carbohydrate polymers |
| 05/10/2002 | WO2002037102A2 Methods for analyzing dynamic changes in cellular informatics |
| 05/10/2002 | WO2002037077A2 Screening methods based on transcriptional regulation analysis system using transformed cell lines |
| 05/10/2002 | WO2002036832A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/10/2002 | WO2002036831A2 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof |
| 05/10/2002 | WO2002036830A2 Method of determining gene copy number |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036828A2 COMPOSITIONS AND SYSTEMS FOR IDENTIFYING AND COMPARING EXPRESSED GENES (mRNAs) IN EUKARYOTIC ORGANISMS |
| 05/10/2002 | WO2002036827A1 Bacterial strain typing |
| 05/10/2002 | WO2002036826A2 Del-1 and benign prostatic hyperplasia |
| 05/10/2002 | WO2002036825A1 Single nucleotide polymorphisms |
| 05/10/2002 | WO2002036824A1 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 05/10/2002 | WO2002036822A1 Method of determining nucleic acid base sequence |
| 05/10/2002 | WO2002036821A2 Method for the amplification and optional characterisation of nucleic acids |
| 05/10/2002 | WO2002036820A2 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 05/10/2002 | WO2002036819A1 BRCA1 AND hMLH1 GENE PRIMER SEQUENCES AND METHOD FOR TESTING |
| 05/10/2002 | WO2002036818A2 Method for detecting inhibitors of tumour growth |
| 05/10/2002 | WO2002036817A2 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis |
| 05/10/2002 | WO2002036816A2 Method of determining susceptibility to diseases |
| 05/10/2002 | WO2002036815A2 Genetic analysis of microorganisms |
| 05/10/2002 | WO2002036814A2 Diagnosis of diseases associated with cdk4 by determining the methylation state of the cdk4 |
| 05/10/2002 | WO2002036813A2 Detection of rare candida species |
| 05/10/2002 | WO2002036812A2 Nonlinear system identification for class prediction in bioinformatics and related applications |
| 05/10/2002 | WO2002036811A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | WO2002036808A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/10/2002 | WO2002036807A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036805A2 Scar test for the authentication of chinese medicinal materials |
| 05/10/2002 | WO2002036804A2 Method for detecting hematopoietic stem cells |
| 05/10/2002 | WO2002036791A2 Nucleus export reporter system |
| 05/10/2002 | WO2002036789A2 Methods of modifying eukaryotic cells |
| 05/10/2002 | WO2002036784A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036756A2 Lactobacillus strain, and plasmid hosted by same |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036738A2 Affinity maturation by competitive selection |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036624A2 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof |
| 05/10/2002 | WO2002036621A1 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 05/10/2002 | WO2002036610A2 Haplotypes of the adora3 gene |
| 05/10/2002 | WO2002036608A2 Haplotypes of the cyp1a2 gene |
| 05/10/2002 | WO2002036604A2 Diagnosis of diseases associated with the human c-mos gene |
| 05/10/2002 | WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
| 05/10/2002 | WO2002022859A3 Assessment of ecosystem health by evaluating multiple biomarkers in a nonhuman organism |
| 05/10/2002 | WO2002018342A3 Novel autoinducer molecules and uses therefor |
| 05/10/2002 | WO2002008461A3 A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS |
| 05/10/2002 | WO2001098338A3 Fluorescent proteins |
| 05/10/2002 | WO2001093669A3 Compound screens relating to insulin deficiency or insulin resistance |
| 05/10/2002 | WO2001092477A3 Three-dimensional skin model |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001090304A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001088116A3 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 05/10/2002 | WO2001087906A3 Haplotypes of the stk11 gene |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001083771A3 Human phospholipase c delta 5 |
| 05/10/2002 | WO2001074845A3 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof |
| 05/10/2002 | WO2001073445A3 Method for analyzing soluble fibrin |
| 05/10/2002 | WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 05/10/2002 | WO2001069260A3 A lysosomal pepstatin-insensitive proteinase as a novel biomarker for detecting and diagnosing breast cancer |
| 05/10/2002 | WO2001067102A3 Detection of chitin-containing contaminants such as microorganisms |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001055323A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001051620A3 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 05/10/2002 | WO2001049872A3 Diagnostic analytical method and kit |
| 05/10/2002 | WO2001048670A3 A method for the identification of gene transcripts with improved efficiency in the treatment of errors |